gadolinium dtpa has been researched along with Neoplasms, Nerve Tissue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Essig, M; Gerigk, L; Giesel, FL; Griffiths, PD; Kauczor, HU; Mehndiratta, A; Politi, M; Risse, F; Rius, M; von Tengg-Kobligk, H; Wilkinson, ID; Zechmann, CM | 1 |
| Breger, RK; Daniels, DL; Haughton, VM; Papke, RA; Pojunas, KW; Williams, AL | 1 |
2 trial(s) available for gadolinium dtpa and Neoplasms, Nerve Tissue
| Article | Year |
|---|---|
Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
Topics: Adult; Aged; Brain; Brain Mapping; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Nerve Tissue; Organometallic Compounds | 2009 |
Benign extraaxial tumors: contrast enhancement with Gd-DTPA.
Topics: Adenoma; Clinical Trials as Topic; Contrast Media; Gadolinium; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Magnetic Resonance Spectroscopy; Neoplasms, Nerve Tissue; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms | 1987 |